NCT02666794

Brief Summary

Combined spinal-epidural (CSE) for labor analgesia has been associated with fetal bradycardia and uterine hypertonia, possibly due to asymmetric decrease in catecholamine levels, when compared with epidural analgesia (EP).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 28, 2016

Completed
1.5 years until next milestone

Study Start

First participant enrolled

July 12, 2017

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 16, 2020

Completed
Last Updated

March 8, 2022

Status Verified

March 1, 2022

Enrollment Period

3.3 years

First QC Date

December 21, 2015

Last Update Submit

March 4, 2022

Conditions

Keywords

analgesiafetal bradycardiahypertonic uterine

Outcome Measures

Primary Outcomes (3)

  • Cathecolamines levels

    Pattern of cathecolamines levels

    at the moment of analgesia and 20 minutes after

  • Fetal bradycardia

    Fetal bradycardia is defined as the baseline drops to less than 100 bpm

    15 minutes before analgesia and 30 minutes after continuously

  • Increase in uterine tone

    Increase in uterine tone (qualitative measure)

    15 minutes before analgesia and 30 minutes after continuously

Secondary Outcomes (1)

  • Maternal hipotension

    30 minutes after analgesia (measures every 5 minutes)

Other Outcomes (3)

  • Pain scores

    20 minutes after analgesia (measures every 5 minutes)

  • APGAR score

    At birth

  • Fetal acidosis

    At birth

Study Arms (2)

Puncture epidural

ACTIVE COMPARATOR

Women in labor the epidural group will receive epidural bupivacaine with vasoconstrictor 0.125% 10 ml plus 20 micrograms sufentanil, followed by the placement of the epidural catheter

Drug: Epidural bupivacaine with vasoconstrictor 0.125%Drug: Epidural sufentanilProcedure: Placement of the epidural catheter

Puncture combined spinal-epidural

ACTIVE COMPARATOR

The mothers of the combined spinal-epidural analgesia group will receive intrathecal hyperbaric bupivacaine solution 0.5% 2.5 mg plus 5.0 micrograms of sufentanil and plus 60 micrograms of morphine, followed by placement of an epidural catheter to the catheter through technical needle

Drug: Intrathecal hyperbaric bupivacaine solution 0.5%Drug: Intrathecal morphineProcedure: Placement of an epidural catheter to the catheter through technical needleDrug: Intrathecal sufentanil

Interventions

20 mcg

Puncture epidural

Placement of the epidural catheter

Puncture epidural

2.5 mg

Puncture combined spinal-epidural

60 mcg

Puncture combined spinal-epidural

Placement of an epidural catheter to the catheter through technical needle

Puncture combined spinal-epidural

5 mcg

Puncture combined spinal-epidural

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Contraindications to interventions, either due to severe comorbidity or contraindication to neuraxial block; previous use of systemic opioids during labor, maternal amniotic infection or known fetal diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shirley Andrade Santos

São Paulo, 05408000, Brazil

Location

Related Publications (8)

  • Baschat AA. Fetal growth restriction - from observation to intervention. J Perinat Med. 2010 May;38(3):239-46. doi: 10.1515/jpm.2010.041.

    PMID: 20205623BACKGROUND
  • Abrao KC, Francisco RPV, Miyadahira S, Cicarelli DD, Zugaib M. Elevation of uterine basal tone and fetal heart rate abnormalities after labor analgesia: a randomized controlled trial. Obstet Gynecol. 2009 Jan;113(1):41-47. doi: 10.1097/AOG.0b013e31818f5eb6.

  • Van de Velde M, Vercauteren M, Vandermeersch E. Fetal heart rate abnormalities after regional analgesia for labor pain: the effect of intrathecal opioids. Reg Anesth Pain Med. 2001 May-Jun;26(3):257-62. doi: 10.1053/rapm.2001.22258.

  • Nielsen PE, Erickson JR, Abouleish EI, Perriatt S, Sheppard C. Fetal heart rate changes after intrathecal sufentanil or epidural bupivacaine for labor analgesia: incidence and clinical significance. Anesth Analg. 1996 Oct;83(4):742-6. doi: 10.1097/00000539-199610000-00014.

  • Collis RE, Davies DW, Aveling W. Randomised comparison of combined spinal-epidural and standard epidural analgesia in labour. Lancet. 1995 Jun 3;345(8962):1413-6. doi: 10.1016/s0140-6736(95)92602-x.

  • Nakamura G, Ganem EM, Rugolo LM, Castiglia YM. Effects on mother and fetus of epidural and combined spinal-epidural techniques for labor analgesia. Rev Assoc Med Bras (1992). 2009 Jul-Aug;55(4):405-9. doi: 10.1590/s0104-42302009000400014.

  • Patel NP, El-Wahab N, Fernando R, Wilson S, Robson SC, Columb MO, Lyons GR. Fetal effects of combined spinal-epidural vs epidural labour analgesia: a prospective, randomised double-blind study. Anaesthesia. 2014 May;69(5):458-67. doi: 10.1111/anae.12602.

  • Simmons SW, Taghizadeh N, Dennis AT, Hughes D, Cyna AM. Combined spinal-epidural versus epidural analgesia in labour. Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD003401. doi: 10.1002/14651858.CD003401.pub3.

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Shirley Santos, MD

    Anesthesiologist

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiologist

Study Record Dates

First Submitted

December 21, 2015

First Posted

January 28, 2016

Study Start

July 12, 2017

Primary Completion

October 16, 2020

Study Completion

October 16, 2020

Last Updated

March 8, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations